文献速递生殖医学

CAMSAP1双等位基因突变导致人类精子头部与鞭毛缺陷型畸形精子症

Bi-allelic mutations of CAMSAP1 result in teratozoospermia with sperm head and flagella defects in humans.
PubMed 文献 · Hum Reprod · 2026-01-01

该研究通过对3757例男性不育患者行全外显子测序,在3例严重精子形态与活力异常患者中鉴定出CAMSAP1双等位基因变异,其中2例为近亲家系纯合变异、1例为非近亲家系复合杂合错义变异。功能实验显示变异蛋白稳定性显著降低,CAMSAP1通过CALM1和SPTBN1偶联manchette微管与核周spectrin-actin网络,其突变破坏该支架导致精子头部多形畸形及MMAF样表型。

要点

  • CAMSAP1双等位基因变异可导致人类畸形精子症伴精子头部多形畸形和MMAF样表型。
  • CAMSAP1与CALM1、SPTBN1结合,偶联manchette微管与核周spectrin-actin网络以完成核塑形。
  • 该发现扩展了精子头部畸形遗传病因谱,为男性不育基因诊断与咨询提供新靶点。

核心结论

  • CAMSAP1双等位基因变异通过破坏manchette微管动力学及微管-spectrin-actin支架导致人类男性不育,表现为多发性精子头部畸形和MMAF样表型。

研究设计与样本

  • 研究对2015至2025年招募的3757例男性不育患者行全外显子测序鉴定CAMSAP1变异,并对3例严重精子形态与活力异常患者开展体外功能实验、免疫共沉淀-质谱及精子形态分析。

主要发现

  • 在2例近亲家系(中国和巴基斯坦)个体中检出CAMSAP1纯合变异,在1例非近亲中国家系个体中检出复合杂合错义变异,均经Sanger测序确认。
  • 患者精子呈现MMAF表型及梨形、无定形、小头、圆头等多样的头部异常。
  • 4个CAMSAP1变异均被预测为有害,体外实验显示蛋白稳定性显著降低。
  • 蛋白质组分析显示CAMSAP1与肌动蛋白细胞骨架组织、顶体囊泡运输、微管束组装及钙调蛋白调控相关蛋白相互作用。
  • 机制上CAMSAP1与CALM1和SPTBN1结合,偶联manchette微管与核周spectrin-actin网络;变异破坏这些相互作用,导致manchette结构缺陷、顶体组装异常和核变形。

临床怎么用

  • 对严重畸形精子症伴精子头部多形畸形及MMAF样表型的男性不育患者,可考虑CAMSAP1基因检测以明确遗传病因。
  • 检出CAMSAP1双等位基因变异可为遗传咨询、生育决策及辅助生殖策略选择提供依据。

局限性

  • CRISPR-Cas9敲入细胞模型无法重现精子形成过程中manchette组装与核重塑的高度动态过程,不能完全捕捉精子头部变形的机制序列。
  • 受累个体数量有限,尚需更大规模多中心、多族裔队列验证CAMSAP1变异的致病性并进一步明确相关临床谱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the role of calmodulin-regulated spectrin-associated protein 1 (CAMSAP1) in human spermatogenesis? SUMMARY ANSWER: Biallelic CAMSAP1 variants cause human male infertility with multiple sperm head deformities and MMAF-like phenotypes by disrupting manchette microtubule dynamics and the microtubule-spectrin-actin scaffold essential for sperm head shaping. WHAT IS KNOWN ALREADY: Sperm head shaping requires coordinated acrosome formation, chromatin condensation, and manchette-driven nuclear remodeling. Although several genes have been implicated in globozoospermia, macrozoospermia, and multiple morphological abnormalities of the sperm flagella (MMAF), the genetic causes of other forms of abnormal sperm head morphology remain largely unknown. Camsap1-deficient mice exhibit severe spermatogenic defects, including abnormal sperm head shaping and flagellar malformations resulting from disruption of the acrosome-acroplaxome-manchette complex, ultimately leading to male infertility. However, whether CAMSAP1 plays a conserved role in human sperm development has not been established. STUDY DESIGN, SIZE, DURATION: The CAMSAP1 variants were identified by whole-exome sequencing in a cohort of 3757 male infertility patients, and all participants were recruited from 2015 to 2025. In vitro functional assays, immunoprecipitation-mass spectrometry, and sperm morphological analyses were performed. PARTICIPANTS/MATERIALS, SETTING, METHODS: Three infertile men with severely impaired sperm morphology and motility were recruited. Bioinformatic assessment, cell-based expression assays, immunostaining, and co-immunoprecipitation (Co-IP) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) using human testicular extracts were used to characterize the functional impact of the variants. MAIN RESULTS AND THE ROLE OF CHANCE: Homozygous CAMSAP1 variants were identified in two individuals from consanguineous families (Chinese and Pakistani), and compound heterozygous missense variants in a third individual from a non-consanguineous Chinese family through whole-exome sequencing and further confirmed by Sanger sequencing. Sperm from affected individuals displayed MMAF phenotypes and diverse head abnormalities, including pyriform, amorphous, small, and globozoospermic forms. All four CAMSAP1 variants were predicted to be damaging and exhibited markedly reduced protein stability in vitro. Proteomic analysis revealed that CAMSAP1 interacts with proteins involved in actin cytoskeleton organization, acrosomal vesicle trafficking, microtubule bundle assembly, and calmodulin regulation. Mechanistically, CAMSAP1 associates with CALM1 and SPTBN1 to couple manchette microtubules with the perinuclear spectrin-actin network, ensuring proper force transmission for nuclear shaping. Mutations disrupted these interactions, leading to defective manchette architecture, abnormal acrosome assembly, and nuclear deformation. LIMITATIONS, REASONS FOR CAUTION: Although CRISPR-Cas9 knock-in cell lines carrying patient-derived CAMSAP1 variants were generated, this in vitro model could not reproduce the highly dynamic processes of manchette assembly and nuclear remodeling that occur uniquely during spermiogenesis, and therefore cannot fully capture the mechanistic sequence leading to sperm head deformation. Additionally, the number of affected individuals remains limited, and larger multi-center, multi-ethnic cohorts will be required to validate the pathogenicity of CAMSAP1 variants and further delineate the associated clinical spectrum. WIDER IMPLICATIONS OF THE FINDINGS: This work identifies CAMSAP1 as a previously unrecognized cause of human asthenoteratozoospermia and expands the genetic landscape of sperm head deformities. The findings underscore the essential role of CAMSAP1 in manchette-mediated nuclear remodeling and provide new insights for genetic diagnosis, counseling, and management of male infertility. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (grant no. 82301815), the National Key R&D Program of China (grant no. 2022YFC2702603), the Sichuan Province Science and Technology Innovation Talent Project (grant no. 2024JDRC0006), the 2024 Key Open Project of Sichuan Provincial Key Laboratory for Human Disease Gene Research (grant no. 2024kflx002), and the China Postdoctoral Science Foundation (grant nos. 2023M732468 and GZC20231835). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Zheng R, Yan J, Zhi W, et al. Bi-allelic mutations of CAMSAP1 result in teratozoospermia with sperm head and flagella defects in humans. Hum Reprod. 2026. PMID: 42114970. doi:10.1093/humrep/deag071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。